These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26690735)

  • 1. Interpreting Thermodynamic Profiles of Aminoadamantane Compounds Inhibiting the M2 Proton Channel of Influenza A by Free Energy Calculations.
    Homeyer N; Ioannidis H; Kolarov F; Gauglitz G; Zikos C; Kolocouris A; Gohlke H
    J Chem Inf Model; 2016 Jan; 56(1):110-26. PubMed ID: 26690735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alchemical Free Energy Calculations and Isothermal Titration Calorimetry Measurements of Aminoadamantanes Bound to the Closed State of Influenza A/M2TM.
    Ioannidis H; Drakopoulos A; Tzitzoglaki C; Homeyer N; Kolarov F; Gkeka P; Freudenberger K; Liolios C; Gauglitz G; Cournia Z; Gohlke H; Kolocouris A
    J Chem Inf Model; 2016 May; 56(5):862-76. PubMed ID: 27105206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers.
    Cady SD; Schmidt-Rohr K; Wang J; Soto CS; Degrado WF; Hong M
    Nature; 2010 Feb; 463(7281):689-92. PubMed ID: 20130653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The boundary lipid around DMPC-spanning influenza A M2 transmembrane domain channels: Its structure and potential for drug accommodation.
    Konstantinidi A; Chountoulesi M; Naziris N; Sartori B; Amenitsch H; Mali G; Čendak T; Plakantonaki M; Triantafyllakou I; Tselios T; Demetzos C; Busath DD; Mavromoustakos T; Kolocouris A
    Biochim Biophys Acta Biomembr; 2020 Mar; 1862(3):183156. PubMed ID: 31846647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between an amantadine analogue and the transmembrane portion of the influenza A M2 protein in liposomes probed by 1H NMR spectroscopy of the ligand.
    Kolocouris A; Hansen RK; Broadhurst RW
    J Med Chem; 2004 Sep; 47(20):4975-8. PubMed ID: 15369403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free Energy Calculations Reveal the Origin of Binding Preference for Aminoadamantane Blockers of Influenza A/M2TM Pore.
    Gkeka P; Eleftheratos S; Kolocouris A; Cournia Z
    J Chem Theory Comput; 2013 Feb; 9(2):1272-81. PubMed ID: 26588768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steered molecular dynamics approach for promising drugs for influenza A virus targeting M2 channel proteins.
    Nguyen H; Le L
    Eur Biophys J; 2015 Sep; 44(6):447-55. PubMed ID: 26033540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence determinants of a transmembrane proton channel: an inverse relationship between stability and function.
    Stouffer AL; Nanda V; Lear JD; DeGrado WF
    J Mol Biol; 2005 Mar; 347(1):169-79. PubMed ID: 15733926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The L46P mutant confers a novel allosteric mechanism of resistance toward the influenza A virus M2 S31N proton channel blockers.
    Musharrafieh R; Lagarias PI; Ma C; Tan GS; Kolocouris A; Wang J
    Mol Pharmacol; 2019 Aug; 96(2):148-157. PubMed ID: 31175183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does influenza virus a escape from amantadine?
    Qin G; Yu K; Shi T; Luo C; Li G; Zhu W; Jiang H
    J Phys Chem B; 2010 Jul; 114(25):8487-93. PubMed ID: 20521806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extension of the free energy workflow FEW towards implicit solvent/implicit membrane MM-PBSA calculations.
    Homeyer N; Gohlke H
    Biochim Biophys Acta; 2015 May; 1850(5):972-982. PubMed ID: 25450172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparisons of the influenza virus A M2 channel binding affinities, anti-influenza virus potencies and NMDA antagonistic activities of 2-alkyl-2-aminoadamantanes and analogues.
    Kolocouris A; Spearpoint P; Martin SR; Hay AJ; López-Querol M; Sureda FX; Padalko E; Neyts J; De Clercq E
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6156-60. PubMed ID: 18947998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An amantadine-sensitive chimeric BM2 ion channel of influenza B virus has implications for the mechanism of drug inhibition.
    Ohigashi Y; Ma C; Jing X; Balannick V; Pinto LH; Lamb RA
    Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18775-9. PubMed ID: 19841275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 19F NMR detection of the complex between amantadine and the receptor portion of the influenza A M2 ion channel in DPC micelles.
    Kolocouris A; Zikos C; Broadhurst RW
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3947-52. PubMed ID: 17502147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free energy calculations on the two drug binding sites in the M2 proton channel.
    Gu RX; Liu LA; Wei DQ; Du JG; Liu L; Liu H
    J Am Chem Soc; 2011 Jul; 133(28):10817-25. PubMed ID: 21711026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance-Mutation (N31) Effects on Drug Orientation and Channel Hydration in Amantadine-Bound Influenza A M2.
    Gleed ML; Ioannidis H; Kolocouris A; Busath DD
    J Phys Chem B; 2015 Sep; 119(35):11548-59. PubMed ID: 26268449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure and function of the influenza A M2 proton channel.
    Cady SD; Luo W; Hu F; Hong M
    Biochemistry; 2009 Aug; 48(31):7356-64. PubMed ID: 19601584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding and Proton Blockage by Amantadine Variants of the Influenza M2
    Tzitzoglaki C; Wright A; Freudenberger K; Hoffmann A; Tietjen I; Stylianakis I; Kolarov F; Fedida D; Schmidtke M; Gauglitz G; Cross TA; Kolocouris A
    J Med Chem; 2017 Mar; 60(5):1716-1733. PubMed ID: 28107633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How amantadine and rimantadine inhibit proton transport in the M2 protein channel.
    Intharathep P; Laohpongspaisan C; Rungrotmongkol T; Loisruangsin A; Malaisree M; Decha P; Aruksakunwong O; Chuenpennit K; Kaiyawet N; Sompornpisut P; Pianwanit S; Hannongbua S
    J Mol Graph Model; 2008 Oct; 27(3):342-8. PubMed ID: 18620883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.